SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 247 filers reported holding SAGE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.22 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,000 | 0.0% | 33 | 0.0% | 0.00% | – |
| Q2 2022 | $1,000 | 0.0% | 33 | -21.4% | 0.00% | – |
| Q1 2022 | $1,000 | -99.7% | 42 | -99.5% | 0.00% | -100.0% |
| Q3 2021 | $354,000 | +378.4% | 7,995 | +515.0% | 0.02% | +533.3% |
| Q2 2021 | $74,000 | +1133.3% | 1,300 | +1429.4% | 0.00% | – |
| Q1 2021 | $6,000 | -14.3% | 85 | +1.2% | 0.00% | -100.0% |
| Q4 2020 | $7,000 | +40.0% | 84 | 0.0% | 0.00% | – |
| Q3 2020 | $5,000 | +66.7% | 84 | +6.3% | 0.00% | – |
| Q2 2020 | $3,000 | 0.0% | 79 | -17.7% | 0.00% | – |
| Q1 2020 | $3,000 | -40.0% | 96 | +33.3% | 0.00% | – |
| Q4 2019 | $5,000 | -64.3% | 72 | -28.7% | 0.00% | -100.0% |
| Q3 2019 | $14,000 | -26.3% | 101 | -1.0% | 0.00% | 0.0% |
| Q2 2019 | $19,000 | +216.7% | 102 | +183.3% | 0.00% | – |
| Q1 2019 | $6,000 | -100.0% | 36 | -98.1% | 0.00% | -100.0% |
| Q2 2018 | $296,781,000 | +470981.0% | 1,896 | +387.4% | 0.03% | +333.3% |
| Q1 2018 | $63,000 | +117.2% | 389 | +117.3% | 0.01% | +200.0% |
| Q4 2017 | $29,000 | +2800.0% | 179 | +1018.8% | 0.00% | – |
| Q3 2017 | $1,000 | – | 16 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Integral Health Asset Management, LLC | 409,000 | $17,399,000 | 4.82% |
| Palo Alto Investors LP | 781,730 | $33,255,000 | 2.12% |
| DAFNA Capital Management LLC | 180,306 | $7,670,000 | 1.93% |
| Boxer Capital, LLC | 1,094,000 | $46,539,000 | 1.81% |
| Deep Track Capital, LP | 500,000 | $21,270,000 | 1.50% |
| Bellevue Group AG | 3,228,004 | $137,319,000 | 1.42% |
| EcoR1 Capital, LLC | 940,636 | $40,015,000 | 1.28% |
| Deep Track Capital, LP | 400,000 | $17,016,000 | 1.20% |
| Artal Group S.A. | 1,000,000 | $42,540,000 | 1.15% |
| SECTOR GAMMA AS | 98,904 | $4,207,000 | 0.99% |